Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

St. Anna Children's Hospital / CCRI Histiocytosis Data Access Committee

ABSTRACT: Data Access Committee EGAC00001001297

PROVIDER: EGAC00001001297 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Expression data for biophenotypic leukemia patients treated in St. Jude Children's Research Hospital

Project description:Mixed-lineage leukemias represent about 3-5% of acute leukemias occurring in patients of all ages and comprise several different subtypes (biphenotypic, bilineal, and lineage switch). The optimal therapeutic approach to these cases, especially in pediatric patients, has not been defined. We used microarrays to detail the gene expression of pediatric patients with biophenotypic leukemia. Keywords: Patient sample accumulation

2009-01-06 | GSE14286 | GEO

SEER Remote Access Pilot Test Data (2018)

Project description:SEER Remote Access Pilot Test Data (2018)

| PRJNA625583 | ENA

SEER Remote Access Pilot Test Data (2018)

Project description:SEER Remote Access Pilot Test Data (2018)

| PRJNA625584 | ENA

Dual ST dataset access committee

Project description:Data Access Committee EGAC00001002635

| EGAC00001002635 | EGA

St James's University Hospital, Leeds

Project description:Data Access Committee EGAC00001000861

| EGAC00001000861 | EGA

Garvan/St Vincent’s Prostate Cancer Tissue and Data Access Committee

Project description:Data Access Committee EGAC00001002769

| EGAC00001002769 | EGA

A mechanism for controlled access to GWAS data: experience of the GAIN Data Access Committee.

Project description:The Genetic Association Information Network (GAIN) Data Access Committee was established in June 2007 to provide prompt and fair access to data from six genome-wide association studies through the database of Genotypes and Phenotypes (dbGaP). Of 945 project requests received through 2011, 749 (79%) have been approved; median receipt-to-approval time decreased from 14 days in 2007 to 8 days in 2011. Over half (54%) of the proposed research uses were for GAIN-specific phenotypes; other uses were for method development (26%) and adding controls to other studies (17%). Eight data-management incidents, defined as compromises of any of the data-use conditions, occurred among nine approved users; most were procedural violations, and none violated participant confidentiality. Over 5 years of experience with GAIN data access has demonstrated substantial use of GAIN data by investigators from academic, nonprofit, and for-profit institutions with relatively few and contained policy violations. The availability of GAIN data has allowed for advances in both the understanding of the genetic underpinnings of mental-health disorders, diabetes, and psoriasis and the development and refinement of statistical methods for identifying genetic and environmental factors related to complex common diseases.

| S-EPMC3617375 | biostudies-literature

Tampere University Hospital Leukemia Research Data Access Committee

Project description:Data Access Committee EGAC00001002489

| EGAC00001002489 | EGA

Tampere University Hospital Leukemia Research Data Access Committee

Project description:Data Access Committee EGAC00001003137

| EGAC00001003137 | EGA

Tampere University Hospital Leukemia Reserach Data Access Committee

Project description:Data Access Committee EGAC00001002445

| EGAC00001002445 | EGA